HSA — authorised 30 November 1995
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
HSA authorised Amaryl on 30 November 1995
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 30 November 1995.
SANOFI AVENTIS US holds the Singaporean marketing authorisation.